Skip to main content
Journal cover image

Haemopoietic stem-cell transplantation for systemic sclerosis.

Publication ,  Journal Article
Sullivan, KM; Wigley, FM; Denton, CP; van Laar, JM; Furst, DE
Published in: Lancet
January 21, 2012

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Lancet

DOI

EISSN

1474-547X

Publication Date

January 21, 2012

Volume

379

Issue

9812

Start / End Page

219

Location

England

Related Subject Headings

  • Scleroderma, Systemic
  • Male
  • Immunosuppressive Agents
  • Humans
  • Hematopoietic Stem Cell Transplantation
  • General & Internal Medicine
  • Female
  • Early Termination of Clinical Trials
  • Cyclophosphamide
  • 42 Health sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sullivan, K. M., Wigley, F. M., Denton, C. P., van Laar, J. M., & Furst, D. E. (2012). Haemopoietic stem-cell transplantation for systemic sclerosis. Lancet, 379(9812), 219. https://doi.org/10.1016/S0140-6736(12)60100-7
Sullivan, Keith M., Frederick M. Wigley, Christopher P. Denton, Jacob M. van Laar, and Daniel E. Furst. “Haemopoietic stem-cell transplantation for systemic sclerosis.Lancet 379, no. 9812 (January 21, 2012): 219. https://doi.org/10.1016/S0140-6736(12)60100-7.
Sullivan KM, Wigley FM, Denton CP, van Laar JM, Furst DE. Haemopoietic stem-cell transplantation for systemic sclerosis. Lancet. 2012 Jan 21;379(9812):219.
Sullivan, Keith M., et al. “Haemopoietic stem-cell transplantation for systemic sclerosis.Lancet, vol. 379, no. 9812, Jan. 2012, p. 219. Pubmed, doi:10.1016/S0140-6736(12)60100-7.
Sullivan KM, Wigley FM, Denton CP, van Laar JM, Furst DE. Haemopoietic stem-cell transplantation for systemic sclerosis. Lancet. 2012 Jan 21;379(9812):219.
Journal cover image

Published In

Lancet

DOI

EISSN

1474-547X

Publication Date

January 21, 2012

Volume

379

Issue

9812

Start / End Page

219

Location

England

Related Subject Headings

  • Scleroderma, Systemic
  • Male
  • Immunosuppressive Agents
  • Humans
  • Hematopoietic Stem Cell Transplantation
  • General & Internal Medicine
  • Female
  • Early Termination of Clinical Trials
  • Cyclophosphamide
  • 42 Health sciences